New diabetes clinical trial: The Impact of Sitagliptin as an Add on Therapy With Closed Loop Control in Adolescents With Diabetic Nephropathy

Published on: November 02, 2023 at 11:00PM
Conditions: Type 1 Diabetic Nephropathy
Interventions: Drug: oral sitagliptin supplementation
Sponsors: Ain Shams University; Ahram Canadian University
Completed
https://ift.tt/x83U7bp